ValuentumAd

Official PayPal Seal

Clorox Misses Consensus Estimates in Its Fiscal Third Quarter

publication date: Jun 28, 2025
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Image: Clorox’s shares have been under pressure more recently. 

Year-to-date, Clorox’s net cash provided by operations was $687 million compared to $355 million in the year-ago period, representing a 94% increase. For fiscal 2025, Clorox expects net sales to be down 1% to flat and adjusted organic sales to be up about 2%. Gross margin is now expected to be up about 150 basis points, with margin enhancement efforts more than offsetting cost inflation, high trade promotion spending, and higher costs from recently implemented tariffs. Adjusted earnings per share is expected to be between $6.95-$7.35, up 13% and 19%, respectively, and the midpoint slightly higher than consensus. Clorox ended the quarter with $2.5 billion in debt and $226 million in cash. We’re steering clear of Clorox due in part to its weak revenue performance and large net debt position. Shares yield 4.1% at the time of this writing.


Subscribe Now to Gain Access!

This page is available to subscribers only. To gain access to members only content (including this research piece), click here to subscribe. With a subscription, you'll have access to all of our premium commentary, equity reports, dividend reports and Best Ideas Newsletter and Dividend Growth Newsletter, as well as receive discounts on all of our modeling tools and products. Financial advisers and institutional investors have even more to choose from!

Click to Learn More about Valuentum

If you are already a subscriber, please login.

If you believe you should be able to view this area then please contact us and we will try to rectify this issue as soon as possible.


To gain access to the members only content, click here to subscribe. You will be given immediate access to premium content on the site.